Celsius Holdings, Inc. ( CELH ) Q3 2025 Earnings Call November 6, 2025 8:00 AM EST Company Participants Paul Wiseman - Senior Vice President of Communications & Investor Relations John Fieldly - CEO & Chairman Jarrod Langhans - Chief Financial Officer Conference Call Participants Gerald Pascarelli - Needham & Company, LLC, Research Division Kaumil Gajrawala - Jefferies LLC, Research Division Michael Lavery - Piper Sandler & Co., Research Division Eric Serotta - Morgan Stanley, Research Division Bonnie Herzog - Goldman Sachs Group, Inc., Research Division Sean McGowan - ROTH Capital Partners, LLC, Research Division Jon Andersen - William Blair & …

Bombardier Inc. ( BBD.B:CA ) Q3 2025 Earnings Call November 6, 2025 8:00 AM EST Company Participants Francis Richer de La Fleche - Vice President of Financial Planning & Investor Relations Eric Martel - President, CEO & Director Bart Demosky - Executive VP & CFO Conference Call Participants Tim James - TD Cowen, Research Division Myles Walton - Wolfe Research, LLC Benoit Poirier - Desjardins Securities Inc., Research Division Gavin Parsons - UBS Investment Bank, Research Division Cameron Doerksen - National Bank Financial, Inc., Research Division Jordan Lyonnais - BofA Securities, Research Division Alexander Ladd - JPMorgan Chase & Co, …

Coherent Corp. ( COHR ) Q1 2026 Earnings Call November 5, 2025 5:00 PM EST Company Participants Paul Silverstein - Vice President of Investor Relations James Anderson - CEO, President & Employee Director Sherri Luther - CFO & Treasurer Conference Call Participants Samik Chatterjee - JPMorgan Chase & Co, Research Division Simon Leopold - Raymond James & Associates, Inc., Research Division George Notter - Wolfe Research, LLC Blayne Curtis - Jefferies LLC, Research Division Thomas O'Malley - Barclays Bank PLC, Research Division Papa Sylla - Citigroup Inc., Research Division Michael Mani - BofA Securities, Research Division Meta Marshall - Morgan …

LOS ANGELES, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises DexCom, Inc., (“DexCom” or the "Company") (NASDAQ: DXCM) investors off a class action on behalf of investors that bought securities between July 26, 2024 and September 17, 2025, inclusive (the “Class Period”). DexCom investors have until December 26, 2025 to file a lead plaintiff motion.

Investors need to pay close attention to BSAC stock based on the movements in the options market lately.

CARTHAGE, Mo. , Nov. 6, 2025 /PRNewswire/ -- Leggett & Platt's Board of Directors declared a dividend of $.05 per share for the fourth quarter of 2025.

BOCA RATON, FL, Nov. 06, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”), the first public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced that the dividend-warrants declared on October 8, 2025, are now listed and trading on the Nasdaq Capital Market under the ticker symbol DFDVW. As previously disclosed, the Company distributed one (1) warrant for each ten (10) shares of common stock held as of the record date of October 23, 2025.

Palantir Technologies Inc. continues to sparkle with robust revenue growth, stellar free cash flow, and industry-leading Rule of 40 metrics, confounding skeptics. Despite operational excellence and rapid enterprise adoption, PLTR stock's valuation remains extremely stretched, trading at over 200x forward P/E or 151x EBITDA. Wall Street and retail investors are divided, with the retail army undeterred by the skepticism, while being rewarded by management's execution and earnings beats.

LOS ANGELES, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises CarMax, Inc., (“CarMax” or the "Company") (NYSE: KMX) investors off a class action on behalf of investors that bought securities between March 5, 2024 and October 8, 2025, inclusive (the “Class Period”). CarMax, Inc. investors have until January 2, 2025 to file a lead plaintiff motion.

NEW YORK--(BUSINESS WIRE)---- $KBR #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against KBR, Inc. (“KBR” or the “Company”) (NYSE: KBR). Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See www.faruqilaw.com. On June 19, 2025, after market close, HomeSafe Alliance issued a press.

Centrus Energy failed to meet analysts' top- and bottom-line estimates for Q3 2025. The company announced an equity offering of up to $1 billlion.

D-Wave Quantum posts a wider Q3 loss but double revenues year over year, lifts margins sharply and gains on strong customer momentum.

SLF's Q3 results reflect higher investment earnings, improved credit experience, strong sales momentum and in-force business growth.

ROKU, FOXA and CBOE made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on Nov. 6, 2025.

Dillard's (DDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The headline numbers for Dentsply (XRAY) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

CALGARY, Alberta--(BUSINESS WIRE)--DevvStream Corp. (Nasdaq: DEVS) (“DevvStream” or the “Company”), a leading carbon management and environmental-asset monetization firm, today announced financial results for its fiscal year ended July 31, 2025, and provided an update on strategic initiatives designed to enhance liquidity, expand technology capabilities, and position the Company for scalable, acquisition-driven growth. Fiscal 2025 Highlights Completed Nasdaq listing and de-SPAC transaction, est.

The headline numbers for BCE (BCE) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Although the revenue and EPS for Immunocore (IMCR) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Although the revenue and EPS for Cogent (CCOI) give a sense of how its business performed in the quarter ended September 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.